Cargando…
Development of a nonhuman primate challenge model to evaluate CD8(+) T cell responses to an adenovirus-based vaccine expressing SIV proteins upon repeat-dose treatment with checkpoint inhibitors
Targeting immune checkpoint receptors expressed in the T cell synapse induces active and long-lasting antitumor immunity in preclinical tumor models and oncology patients. However, traditional nonhuman primate (NHP) studies in healthy animals have thus far demonstrated little to no pharmacological a...
Autores principales: | Graveline, Richard, Haida, Morad, Dumont, Carolyne, Poulin, Dominic, Poitout-Belissent, Florence, Samadfam, Rana, Kronenberg, Sven, Regenass-Lechner, Franziska, Prell, Rodney, Piche, Marie-Soleil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726661/ https://www.ncbi.nlm.nih.gov/pubmed/34923919 http://dx.doi.org/10.1080/19420862.2021.1979447 |
Ejemplares similares
-
Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV
por: Wilkins, Jordan, et al.
Publicado: (2016) -
Where the Wild Things Are: Pathogenesis of SIV Infection in African Nonhuman Primate Hosts
por: Pandrea, Ivona, et al.
Publicado: (2010) -
Nonhuman Primate Adenoviruses of the Human Adenovirus B Species Are Potent and Broadly Acting Oncolytic Vector Candidates
por: Bots, Selas T.F., et al.
Publicado: (2022) -
Use of recombinant cytokines for optimized induction of antiviral immunity against SIV in the nonhuman primate model of human AIDS
por: Ansari, Aftab A., et al.
Publicado: (2004) -
The Immunological Impact of Adenovirus Early Genes on Vaccine-Induced Responses in Mice and Nonhuman Primates
por: Sangare, Kotou, et al.
Publicado: (2021)